Recording: Management of metastatic kidney cancer
This recording will show the latest indications for the medical treatment of metastatic renal cell carcinoma (RCC) according to the evidence showed in literature and at the ASCO GU 2023 congress.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Not approved |
| Duration | Approx. 60 minutes |
Lectures will highlight the first-line and second-line treatment in this stage of the disease. The last part of the recording will focus on the clinical management of adverse events following systemic treatment in metastatic RCC.
Speaker(s):
- Dr. L. Antonuzzo (IT)
- Prof. A. Volpe (IT)
Acknowledgment
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.